Analystreport

CytomX Therapeutics Inc (NASDAQ: CTMX) was given a new $40.00 price target on by analysts at Cantor Fitzgerald. They now have a "buy" rating on the stock.

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com